Stock comparison
BIOGEN INC. is 2.2x more valuable than EXELIXIS, INC. by market capitalization ($36.75 B vs $16.93 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
BIIB is larger
BIOGEN INC. is 2.2x more valuable than EXELIXIS, INC. by market capitalization ($36.75 B vs $16.93 B).
Market value leader
BIIB
BIOGEN INC. is 2.2x more valuable than EXELIXIS, INC. by market capitalization ($36.75 B vs $16.93 B).
Revenue leader
BIIB
EXEL: $2.32B vs BIIB: $9.89B.
Profit leader
BIIB
EXEL: $782.60M vs BIIB: $1.29B.
Margin leader
EXEL
EXEL: 33.7% vs BIIB: 13.1% net margin.
| Metric | EXEL | BIIB |
|---|---|---|
| Market cap | $16.93 B | $36.75 B |
| US-listed rank | #677 | #401 |
| Revenue (latest FY) | $2.32B | $9.89B |
| Net income (latest FY) | $782.60M | $1.29B |
| Net margin | 33.7% | 13.1% |
| P/E (trailing FY) | 21.6x | 28.4x |
| SEC filings | 2,488 | 2,692 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
BIOGEN INC. is 2.2x more valuable than EXELIXIS, INC. by market capitalization ($36.75 B vs $16.93 B).
In their latest fiscal years, EXELIXIS, INC. reported $2.32B in revenue while BIOGEN INC. reported $9.89B.
Full pages: EXELIXIS, INC. and BIOGEN INC., or browse the full rankings.